Search Results

There are 4636 results for: content related to: No resistance to tenofovir disoproxil fumarate detected after up to 144 weeks of therapy in patients monoinfected with chronic hepatitis B virus

  1. Monotherapy with tenofovir disoproxil fumarate for multiple drug-resistant chronic hepatitis B: 3-year trial


    Young-Suk Lim, Yung Sang Lee, Geum-Youn Gwak, Kwan Soo Byun, Yoon Jun Kim, Jonggi Choi, Jihyun An, Han Chu Lee, Byung Chul Yoo and So Young Kwon

    Version of Record online : 18 JUL 2017, DOI: 10.1002/hep.29187

  2. You have free access to this content
    The tracheae defective gene encodes a bZIP protein that controls tracheal cell movement during Drosophila embryogenesis

    The EMBO Journal

    Volume 16, Issue 23, December 1, 1997, Pages: 7156–7165, Karsten G. Eulenberg and Reinhard Schuh

    Version of Record online : 1 DEC 1997, DOI: 10.1093/emboj/16.23.7156

  3. Tenofovir-based alternate therapies for chronic hepatitis B patients with partial virological response to entecavir

    Journal of Viral Hepatitis

    Volume 22, Issue 8, August 2015, Pages: 675–681, L. Lu, B. Yip, H. Trinh, C. Q. Pan, S.-H. B. Han, C. C. Wong, J. Li, S. Chan, G. Krishnan, C. C. Wong and M. H. Nguyen

    Version of Record online : 24 NOV 2014, DOI: 10.1111/jvh.12368

  4. Review article: long-term safety of nucleoside and nucleotide analogues in HBV-monoinfected patients

    Alimentary Pharmacology & Therapeutics

    Volume 44, Issue 1, July 2016, Pages: 16–34, P. Lampertico, H. L. Y. Chan, H. L. A. Janssen, S. I. Strasser, R. Schindler and T. Berg

    Version of Record online : 19 MAY 2016, DOI: 10.1111/apt.13659

  5. Tenofovir versus tenofovir plus entecavir for chronic hepatitis B with lamivudine resistance and entecavir resistance

    Journal of Viral Hepatitis

    Volume 24, Issue 2, February 2017, Pages: 141–147, S. Lee, S. H. Ahn, K. S. Jung, D. Y. Kim, B. K. Kim, S. U. Kim, O. Baatarkhuu, H. J. Ku, K. Han and J. Y. Park

    Version of Record online : 20 OCT 2016, DOI: 10.1111/jvh.12623

  6. You have free access to this content
    Prolonged use of tenofovir in HIV/hepatitis B virus (HBV)-coinfected individuals does not lead to HBV polymerase mutations and is associated with persistence of lamivudine HBV polymerase mutations

    HIV Medicine

    Volume 10, Issue 4, April 2009, Pages: 229–235, J Audsley, N Arrifin, LKW Yuen, A Ayres, SM Crowe, A Bartholomeusz, SA Locarnini, A Mijch, SR Lewin and J Sasadeusz

    Version of Record online : 28 JAN 2009, DOI: 10.1111/j.1468-1293.2008.00675.x

  7. You have free access to this content
    No detectable resistance to tenofovir disoproxil fumarate after 6 years of therapy in patients with chronic hepatitis B


    Volume 59, Issue 2, February 2014, Pages: 434–442, Kathryn M. Kitrinos, Amoreena Corsa, Yang Liu, John Flaherty, Andrea Snow-Lampart, Patrick Marcellin, Katyna Borroto-Esoda and Michael D. Miller

    Version of Record online : 6 NOV 2013, DOI: 10.1002/hep.26686

  8. Tenofovir-based rescue therapy for chronic hepatitis B patients who had failed treatment with lamivudine, adefovir, and entecavir

    Journal of Gastroenterology and Hepatology

    Volume 30, Issue 10, October 2015, Pages: 1514–1521, Byung Gyu Kim, Seok Won Jung, Eun Hye Kim, Jae Hee Kim, Ju Hwan Park, Shi Jung Sung, Bo Ryung Park, Min-Ho Kim, Chang Jae Kim, Byung Uk Lee, Jae Ho Park, In Du Jeong, Sung-Jo Bang, Jung Woo Shin and Neung Hwa Park

    Version of Record online : 11 SEP 2015, DOI: 10.1111/jgh.12993

  9. Association of tenofovir disoproxil fumarate with primary allograft survival in HIV-positive kidney transplant recipients

    Transplant Infectious Disease

    Volume 19, Issue 4, August 2017, Suzanne M. Boyle, Gregory Malat, Meera N. Harhay, Dong H. Lee, Lisa Pang, Sindhura Talluri, Akshay Sharma, Tiffany E. Bias, Karthik Ranganna and Alden M. Doyle

    Version of Record online : 28 JUL 2017, DOI: 10.1111/tid.12727

  10. You have full text access to this OnlineOpen article
    Diet quality influences isotopic discrimination among amino acids in an aquatic vertebrate

    Ecology and Evolution

    Volume 5, Issue 10, May 2015, Pages: 2048–2059, Yoshito Chikaraishi, Shawn A. Steffan, Yoshinori Takano and Naohiko Ohkouchi

    Version of Record online : 25 APR 2015, DOI: 10.1002/ece3.1491

  11. Predictors of response to tenofovir disoproxil fumarate plus peginterferon alfa-2a combination therapy for chronic hepatitis B

    Alimentary Pharmacology & Therapeutics

    Volume 44, Issue 9, November 2016, Pages: 957–966, P. Marcellin, S. H. Ahn, W.-L. Chuang, A. J. Hui, F. Tabak, R. Mehta, J. Petersen, C.-M. Lee, X. Ma, F. A. Caruntu, W. Y. Tak, M. Elkhashab, L. Lin, G. Wu, E. B Martins, P. Charuworn, L. J. Yee, S. G. Lim, G. R. Foster, S. Fung, L. Morano, D. Samuel, K. Agarwal, R. Idilman, S. I. Strasser, M. Buti, G. B. Gaeta, G. Papatheodoridis, R. Flisiak and H. L. Y. Chan

    Version of Record online : 15 SEP 2016, DOI: 10.1111/apt.13779

  12. Crystal Structure and Desolvation Behaviour of the Tadalafil Monosolvates with Acetone and Methyl Ethyl Ketone

    Journal of Pharmaceutical Sciences

    Volume 104, Issue 11, November 2015, Pages: 3782–3788, Maria O. Miclaus, Irina E. Kacso, Flavia A. Martin, Leontin David, Mihaela M. Pop, Claudiu Filip and Xenia Filip

    Version of Record online : 24 JUL 2015, DOI: 10.1002/jps.24597

  13. You have full text access to this OnlineOpen article
    Efficacy of tenofovir disoproxil fumarate at 240 weeks in patients with chronic hepatitis B with high baseline viral load


    Volume 58, Issue 2, August 2013, Pages: 505–513, Stuart C. Gordon, Zahary Krastev, Andrzej Horban, Jörg Petersen, Jan Sperl, Phillip Dinh, Eduardo B. Martins, Leland J. Yee, John F. Flaherty, Kathryn M. Kitrinos, Vinod K. Rustgi and Patrick Marcellin

    Version of Record online : 3 MAY 2013, DOI: 10.1002/hep.26277

  14. You have free access to this content
    Raltegravir-emtricitabine-tenofovir as HIV nonoccupational post-exposure prophylaxis in men who have sex with men: safety, tolerability and adherence

    HIV Medicine

    Volume 15, Issue 1, January 2014, Pages: 13–22, J McAllister, P Read, A McNulty, WWY Tong, A Ingersoll and A Carr

    Version of Record online : 6 SEP 2013, DOI: 10.1111/hiv.12075

  15. You have full text access to this OnlineOpen article
    Embracing variability in amino acid δ15N fractionation: mechanisms, implications, and applications for trophic ecology


    Volume 7, Issue 12, December 2016, Kelton W. McMahon and Matthew D. McCarthy

    Version of Record online : 21 DEC 2016, DOI: 10.1002/ecs2.1511

  16. Intensification with pegylated interferon during treatment with tenofovir in HIV–hepatitis B virus co-infected patients

    Journal of Viral Hepatitis

    Volume 23, Issue 12, December 2016, Pages: 1017–1026, A. Boyd, L. Piroth, S. Maylin, M. Maynard-Muet, F. Lebossé, C. Bouix, C. Lascoux-Combe, N. Mahjoub, P.-M. Girard, C. Delaugerre, F. Carrat, K. Lacombe and P. Miailhes

    Version of Record online : 3 AUG 2016, DOI: 10.1111/jvh.12581

  17. You have free access to this content
    Structural investigation of tumor differentiation factor

    Biotechnology and Applied Biochemistry

    Volume 59, Issue 6, November-December 2012, Pages: 445–450, Urmi Roy, Izabela Sokolowska, Alisa G. Woods and Costel C. Darie

    Version of Record online : 20 NOV 2012, DOI: 10.1002/bab.1046

  18. Cost-effectiveness analysis of tenofovir/emtricitabine and abacavir/lamivudine in combination with efavirenz or atazanavir/ritonavir for treatment-naïve adults with HIV-1 infection in the UK, based on the AIDS Clinical Trials Group 5202 clinical trial

    HIV Medicine

    Volume 17, Issue 7, August 2016, Pages: 505–515, E Wilkins, M Fisher, AJ Brogan, SE Talbird and EM La

    Version of Record online : 9 DEC 2015, DOI: 10.1111/hiv.12349

  19. You have free access to this content
    Transdermal fentanyl for cancer pain

    Intervention Review

    The Cochrane Library

    Gina Hadley, Sheena Derry, R Andrew Moore and Philip J Wiffen

    Published Online : 5 OCT 2013, DOI: 10.1002/14651858.CD010270.pub2

  20. You have free access to this content
    Is zidovudine first-line therapy virologically comparable to tenofovir in resource-limited settings?

    Tropical Medicine & International Health

    Volume 20, Issue 7, July 2015, Pages: 914–918, Niklaus D. Labhardt, Joëlle Bader, Thabo Ismael Lejone, Isaac Ringera, Daniel Puga, Tracy R. Glass and Thomas Klimkait

    Version of Record online : 2 APR 2015, DOI: 10.1111/tmi.12509